# PharmacoEconomics - Open

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/pharmacoeconomics-open/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 3,490 |
| Citations | 6,992 |
| h-index | 39 |
| Homepage | https://link.springer.com/journal/41669 |
| Open Access | true |
| ISSN-L | 2509-4254 |
| ISSNs | 2509-4254,2509-4262 |
| OpenAlex ID | https://openalex.org/S4210206322 |
| Publisher | Adis, Springer Healthcare |
| Works | 666 |

## Journal papers

Showing 12 of 17.

- [Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials](https://scholariq.org/papers/costs-of-acute-headache-medication-use-and-productivity-losses-among-patients/)
- [Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review](https://scholariq.org/papers/economic-burden-and-health-related-quality-of-life-associated-with-current/)
- [The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland](https://scholariq.org/papers/the-cost-effectiveness-of-patiromer-for-the-treatment-of-hyperkalaemia-in/)
- [Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients with Rheumatoid or Psoriatic Arthritis](https://scholariq.org/papers/impact-of-plan-level-access-restrictions-on-effectiveness-of-biologics-among/)
- [A Cost-Effectiveness Analysis Comparing the VivaSight Double-Lumen Tube and a Conventional Double-Lumen Tube in Adult Patients Undergoing Thoracic Surgery Involving One-Lung Ventilation](https://scholariq.org/papers/a-cost-effectiveness-analysis-comparing-the-vivasight-double-lumen-tube-and-a/)
- [Value Assessment Frameworks in the United States: A Call for Patient Engagement](https://scholariq.org/papers/value-assessment-frameworks-in-the-united-states-a-call-for-patient-engagement/)
- [Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study](https://scholariq.org/papers/cost-of-illness-in-patients-with-duchenne-muscular-dystrophy-in-portugal-the/)
- [Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis](https://scholariq.org/papers/humanistic-and-economic-burden-of-iga-nephropathy-systematic-literature-reviews/)
- [A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada](https://scholariq.org/papers/a-probabilistic-cost-effectiveness-analysis-of-venetoclax-and-obinutuzumab-as-a/)
- [Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting](https://scholariq.org/papers/long-term-cost-effectiveness-of-oral-semaglutide-versus-empagliflozin-and/)
- [Cost Analysis of a Transition Care Bundle Compared with Usual Care for COPD Patients Being Discharged from Hospital: Evaluation of a Randomized Controlled Trial](https://scholariq.org/papers/cost-analysis-of-a-transition-care-bundle-compared-with-usual-care-for-copd/)
- [The Costs of Industry-Sponsored Drug Trials in Canada](https://scholariq.org/papers/the-costs-of-industry-sponsored-drug-trials-in-canada/)

## Journal top topics

Showing 8 of 25.

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Economic and Environmental Valuation](https://scholariq.org/topics/economic-and-environmental-valuation/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Healthcare Policy and Management](https://scholariq.org/topics/healthcare-policy-and-management/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.